Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 2/20 | 0.53 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | METAP1 | P53582 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDE2A | O00408 | 2/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5076750 | 1.00 | MMP9 (0.53) | MMP9METAP2METAP1MEN1KMT2A | |
| SCHEMBL8576836 | 1.00 | MMP9 (0.53) | MMP9METAP2METAP1MEN1KMT2A | |
| SCHEMBL8580916 | 0.85 | MMP9 (0.51) | MMP9METAP2METAP1MEN1KMT2A | |
| SCHEMBL8037585 | 0.85 | MMP9 (0.51) | MMP9METAP2METAP1MEN1KMT2A | |
| SCHEMBL7567444 | 0.81 | SMN1; SMN2 (0.51) | KMT2ATDP1ALOX5 | |
| SCHEMBL675390 | 0.80 | TAS1R3 (0.40) | MEN1KMT2AHTT | |
| SCHEMBL10170773 | 0.80 | TAS1R3 (0.40) | MEN1KMT2AHTT | |
| SCHEMBL6648721 | 0.80 | TAS1R3 (0.40) | MEN1KMT2AHTT | |
| SCHEMBL22267 | 0.80 | TAS1R3 (0.40) | MEN1KMT2AHTT | |
| SCHEMBL3030564 | 0.80 | TAS1R3 (0.40) | MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065313-A1 | Fungicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-30 | — | — | US | claimed |
| WO-2001062083-A2 | FUNGICIDAL MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-30 | — | — | WO | claimed |
| US-6696497-B2 | FOR USE IN CONTROLLING THE GROWTH OF PHYTOPATHOGENIC FUNGI AT A LOCUS | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-24 | — | — | US | disclosed |
| US-20020065313-A1 | Fungicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065313-A1 | Fungicidal mixtures | CYP1B1, CYP51A1, CYP3A7 | MMP9 2960/4885METAP2 1307/4885METAP1 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.